Private Label CBD Gummies Market to Reach $1.38 Billion by 2036 as Wellness Brands Embrace Outsourced Manufacturing

The private label CBD gummies market is projected to grow from $646.2 million in 2026 to $1.38 billion by 2036, driven by wellness brands outsourcing production to reduce costs and accelerate launches, with white label and broad-spectrum formulations leading demand.

Dallas Metrowire Staff
Business
Private Label CBD Gummies Market to Reach $1.38 Billion by 2036 as Wellness Brands Embrace Outsourced Manufacturing

The private label CBD gummies market is poised for substantial growth, with a projected increase from USD 646.2 million in 2026 to USD 1,382.2 million by 2036, reflecting a compound annual growth rate (CAGR) of 7.9%, according to Future Market Insights (FMI). This expansion is fueled by wellness brands increasingly turning to outsourced manufacturing to expedite product launches and minimize capital investment.

White label gummies are expected to dominate the service model segment, capturing 46.2% of global demand in 2026. Their appeal lies in shorter commercialization timelines and lower formulation costs, allowing new brands to enter the market swiftly. By leveraging existing formulations, manufacturers enable companies to focus on branding and marketing rather than production infrastructure.

Broad-spectrum CBD gummies lead the spectrum category with a 42.8% market share in 2026, driven by consumer preference for THC-free products that retain multiple cannabinoids. This positioning enhances retail acceptance and consumer confidence amid stricter product review procedures.

Brand websites remain the leading sales channel, accounting for 39.6% of demand in 2026. Direct-to-consumer platforms offer greater control over customer education, product positioning, and subscription programs, which are vital for building trust and repeat sales. As regulatory scrutiny increases, digital channels also provide flexibility for updating compliance information.

The United States is the fastest-growing market, with a projected CAGR of 8.5% through 2036, supported by a mature direct-to-consumer ecosystem and widespread private label manufacturing services. Other key markets include Canada (8.1% CAGR), the United Kingdom (7.8%), and Germany (7.5%).

Key players in the market include CBD Nationwide, Extract Labs, cbdMD, Inc., Charlotte's Web Holdings, Inc., CV Sciences, Inc., Medterra CBD LLC, British Cannabis, Cannaray Limited, MediPharm Labs Corp., and Little Green Pharma Ltd. These companies compete on formulation expertise, scalability, compliance support, and packaging capabilities.

For more detailed market forecasts, access the full report at https://www.futuremarketinsights.com/reports/sample/rep-gb-33370.

Blockchain Registration

QR Code for Blockchain Registration